The series of abnormal expressions of lipid metabolism and gluconeogenic signaling pathways that may be induced by the reduction of IL-15 in pan-cancer may lead to the metabolic dysfunction of the body in the development of cancer (Crane et al., 2015; Bohlen et al., 2018; Nadeau and Aguer, 2019). Here, IL15 is linked to cancer.